24 related articles for article (PubMed ID: 4040421)
1. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
Parmar A; Macluskey M; Mc Goldrick N; Conway DI; Glenny AM; Clarkson JE; Worthington HV; Chan KK
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD006386. PubMed ID: 34929047
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review.
Guidi A; Codecà C; Ferrari D
Med Oncol; 2018 Feb; 35(3):37. PubMed ID: 29441454
[TBL] [Abstract][Full Text] [Related]
3. The Globalization of Cooperative Groups.
Valdivieso M; Corn BW; Dancey JE; Wickerham DL; Horvath LE; Perez EA; Urton A; Cronin WM; Field E; Lackey E; Blanke CD
Semin Oncol; 2015 Oct; 42(5):693-712. PubMed ID: 26433551
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy.
Machiels JP; Licitra LF; Haddad RI; Tahara M; Cohen EE
BMC Cancer; 2014 Jun; 14():473. PubMed ID: 24973959
[TBL] [Abstract][Full Text] [Related]
5. A phase II study of pralatrexate with vitamin B12 and folic acid supplementation for previously treated recurrent and/or metastatic head and neck squamous cell cancer.
Ho AL; Lipson BL; Sherman EJ; Xiao H; Fury MG; Apollo A; Seetharamu N; Sima CS; Haque S; Lyo JK; Sales R; Cox L; Pfister DG
Invest New Drugs; 2014 Jun; 32(3):549-54. PubMed ID: 24566705
[TBL] [Abstract][Full Text] [Related]
6. Head and neck cancer: guidelines for chemotherapy.
Catimel G
Drugs; 1996 Jan; 51(1):73-88. PubMed ID: 8741233
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic management of head and neck cancer.
Al-Sarraf M
Cancer Metastasis Rev; 1987; 6(3):181-98. PubMed ID: 3319271
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: a phase II randomized trial.
Lippman SM; Kessler JF; Al-Sarraf M; Alberts DS; Itri LM; Mattox D; Von Hoff DD; Loescher L; Meyskens FL
Invest New Drugs; 1988 Apr; 6(1):51-6. PubMed ID: 3165972
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for squamous cell carcinoma of the head and neck: an overview.
Espinola TE; White JA
J La State Med Soc; 1990 Jul; 142(7):15-8. PubMed ID: 2204670
[TBL] [Abstract][Full Text] [Related]
10. Comparison of methotrexate and cisplatin for patients with advanced squamous cell carcinoma of the head and neck region: a Southwest Oncology Group Study.
Grose WE; Lehane DE; Dixon DO; Fletcher WS; Stuckey WJ
Cancer Treat Rep; 1985 Jun; 69(6):577-81. PubMed ID: 4040421
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): an intergroup trial of the Eastern Cooperative Oncology Group.
Gibson MK; Li Y; Murphy B; Hussain MH; DeConti RC; Ensley J; Forastiere AA;
J Clin Oncol; 2005 May; 23(15):3562-7. PubMed ID: 15908667
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
14. A phase II evaluation of a 3-hour infusion of paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: Southwest Oncology Group study 0007.
Worden FP; Moon J; Samlowski W; Clark JI; Dakhil SR; Williamson S; Urba SG; Ensley J; Hussain MH;
Cancer; 2006 Jul; 107(2):319-27. PubMed ID: 16779801
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
